These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 19383330)

  • 41. Glycoprotein nonmetastatic melanoma protein B (GPNMB) promotes the progression of brain glioblastoma via Na
    Ono Y; Chiba S; Yano H; Nakayama N; Saio M; Tsuruma K; Shimazawa M; Iwama T; Hara H
    Biochem Biophys Res Commun; 2016 Dec; 481(1-2):7-12. PubMed ID: 27836549
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Enhanced Antitumor Activity of an Anti-5T4 Antibody-Drug Conjugate in Combination with PI3K/mTOR inhibitors or Taxanes.
    Shor B; Kahler J; Dougher M; Xu J; Mack M; Rosfjord E; Wang F; Melamud E; Sapra P
    Clin Cancer Res; 2016 Jan; 22(2):383-94. PubMed ID: 26319086
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Gpnmb is a melanosome-associated glycoprotein that contributes to melanocyte/keratinocyte adhesion in a RGD-dependent fashion.
    Tomihari M; Hwang SH; Chung JS; Cruz PD; Ariizumi K
    Exp Dermatol; 2009 Jul; 18(7):586-95. PubMed ID: 19320736
    [TBL] [Abstract][Full Text] [Related]  

  • 44. GPNMB promotes the progression of diffuse large B cell lymphoma via YAP1-mediated activation of the Wnt/β-catenin signaling pathway.
    Wang Z; Ran X; Qian S; Hou H; Dong M; Wu S; Ding M; Zhang Y; Zhang X; Zhang M; Chen Q
    Arch Biochem Biophys; 2021 Oct; 710():108998. PubMed ID: 34280359
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Preparation and characterization of antibody-drug conjugates acting on HER2-positive cancer cells.
    Chiang ZC; Chiu YK; Lee CC; Hsu NS; Tsou YL; Chen HS; Hsu HR; Yang TJ; Yang AS; Wang AH
    PLoS One; 2020; 15(9):e0239813. PubMed ID: 32986768
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Combination of antibodies directed against different ErbB3 surface epitopes prevents the establishment of resistance to BRAF/MEK inhibitors in melanoma.
    Fattore L; Malpicci D; Marra E; Belleudi F; Noto A; De Vitis C; Pisanu ME; Coluccia P; Camerlingo R; Roscilli G; Ribas A; Di Napoli A; Torrisi MR; Aurisicchio L; Ascierto PA; Mancini R; Ciliberto G
    Oncotarget; 2015 Sep; 6(28):24823-41. PubMed ID: 26208478
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Therapeutic potential of an anti-CD79b antibody-drug conjugate, anti-CD79b-vc-MMAE, for the treatment of non-Hodgkin lymphoma.
    Dornan D; Bennett F; Chen Y; Dennis M; Eaton D; Elkins K; French D; Go MA; Jack A; Junutula JR; Koeppen H; Lau J; McBride J; Rawstron A; Shi X; Yu N; Yu SF; Yue P; Zheng B; Ebens A; Polson AG
    Blood; 2009 Sep; 114(13):2721-9. PubMed ID: 19633198
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Therapeutic potential of amanitin-conjugated anti-epithelial cell adhesion molecule monoclonal antibody against pancreatic carcinoma.
    Moldenhauer G; Salnikov AV; Lüttgau S; Herr I; Anderl J; Faulstich H
    J Natl Cancer Inst; 2012 Apr; 104(8):622-34. PubMed ID: 22457476
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The HB22.7-vcMMAE antibody-drug conjugate has efficacy against non-Hodgkin lymphoma mouse xenografts with minimal systemic toxicity.
    Abuhay M; Kato J; Tuscano E; Barisone GA; Sidhu RS; O'Donnell RT; Tuscano JM
    Cancer Immunol Immunother; 2016 Oct; 65(10):1169-75. PubMed ID: 27506529
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Glycoprotein nonmetastatic melanoma protein B accelerates tumorigenesis of cervical cancer in vitro by regulating the Wnt/β-catenin pathway.
    Xu S; Fan Y; Li D; Liu Y; Chen X
    Braz J Med Biol Res; 2018 Nov; 52(1):e7567. PubMed ID: 30484490
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Navitoclax enhances the effectiveness of EGFR-targeted antibody-drug conjugates in PDX models of EGFR-expressing triple-negative breast cancer.
    Zoeller JJ; Vagodny A; Daniels VW; Taneja K; Tan BY; DeRose YS; Fujita M; Welm AL; Letai A; Leverson JD; Blot V; Bronson RT; Dillon DA; Brugge JS
    Breast Cancer Res; 2020 Nov; 22(1):132. PubMed ID: 33256808
    [TBL] [Abstract][Full Text] [Related]  

  • 52. CSE1L silence inhibits the growth and metastasis in gastric cancer by repressing GPNMB via positively regulating transcription factor MITF.
    Li Y; Yuan S; Liu J; Wang Y; Zhang Y; Chen X; Si W
    J Cell Physiol; 2020 Mar; 235(3):2071-2079. PubMed ID: 31347172
    [TBL] [Abstract][Full Text] [Related]  

  • 53. IMGN853, a Folate Receptor-α (FRα)-Targeting Antibody-Drug Conjugate, Exhibits Potent Targeted Antitumor Activity against FRα-Expressing Tumors.
    Ab O; Whiteman KR; Bartle LM; Sun X; Singh R; Tavares D; LaBelle A; Payne G; Lutz RJ; Pinkas J; Goldmacher VS; Chittenden T; Lambert JM
    Mol Cancer Ther; 2015 Jul; 14(7):1605-13. PubMed ID: 25904506
    [TBL] [Abstract][Full Text] [Related]  

  • 54. NRF2 and glutathione are key resistance mediators to temozolomide in glioma and melanoma cells.
    Rocha CR; Kajitani GS; Quinet A; Fortunato RS; Menck CF
    Oncotarget; 2016 Jul; 7(30):48081-48092. PubMed ID: 27344172
    [TBL] [Abstract][Full Text] [Related]  

  • 55. In vitro and in vivo responses of advanced prostate tumors to PSMA ADC, an auristatin-conjugated antibody to prostate-specific membrane antigen.
    Wang X; Ma D; Olson WC; Heston WD
    Mol Cancer Ther; 2011 Sep; 10(9):1728-39. PubMed ID: 21750220
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Discovery of a potential biomarker for immunotherapy of melanoma: PLAC1 as an emerging target.
    Mahmoudi AR; Ghods R; Rakhshan A; Madjd Z; Bolouri MR; Mahmoudian J; Rahdan S; Shokri MR; Dorafshan S; Shekarabi M; Zarnani AH
    Immunopharmacol Immunotoxicol; 2020 Dec; 42(6):604-613. PubMed ID: 33106058
    [TBL] [Abstract][Full Text] [Related]  

  • 57. MiR-508-5p Inhibits the Progression of Glioma by Targeting Glycoprotein Non-metastatic Melanoma B.
    Bao G; Wang N; Li R; Xu G; Liu P; He B
    Neurochem Res; 2016 Jul; 41(7):1684-90. PubMed ID: 27003587
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Human Antibody V
    Chu X; Li W; Hines MG; Lyakhov I; Mellors JW; Dimitrov DS
    Mol Pharm; 2023 May; 20(5):2754-2760. PubMed ID: 37067377
    [TBL] [Abstract][Full Text] [Related]  

  • 59. An anti-HER2 antibody conjugated with monomethyl auristatin E is highly effective in HER2-positive human gastric cancer.
    Li H; Yu C; Jiang J; Huang C; Yao X; Xu Q; Yu F; Lou L; Fang J
    Cancer Biol Ther; 2016 Apr; 17(4):346-54. PubMed ID: 26853765
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Glycoprotein nonmetastatic melanoma protein B extracellular fragment shows neuroprotective effects and activates the PI3K/Akt and MEK/ERK pathways via the Na+/K+-ATPase.
    Ono Y; Tsuruma K; Takata M; Shimazawa M; Hara H
    Sci Rep; 2016 Mar; 6():23241. PubMed ID: 26988030
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.